{"id":"W4410785948","doi":"10.1038/s41591-025-03704-9","title":"Lutetium-177–PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial","year":2025,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Health and Medical Research Council; Australian and New Zealand Urogenital and Prostate Cancer Trials Group; Michael Smith Health Research BC; Prostate Cancer Foundation","keywords":"Cabazitaxel; Lutetium; Medicine; Prostate cancer; Prostate; Oncology; Cancer research; Cancer; Internal medicine; Pharmacology; Chemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001875965,0.0003012023,0.002054111,0.001011583,0.0001029193,0.00001157334,0.0002445361,0.000138361,0.0004658507],"category_scores_gemma":[0.002203687,0.0001329746,0.0004343134,0.004464891,0.0005290282,0.00005548113,0.00006160129,0.0009522975,6.636975e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002928802,"about_ca_system_score_gemma":0.0009875044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008952246,"about_ca_topic_score_gemma":0.000581476,"domain_scores_codex":[0.9968771,0.0004779738,0.0009265144,0.0004421277,0.0008554234,0.0004208507],"domain_scores_gemma":[0.9976063,0.001068606,0.0003501715,0.0005490464,0.0003119929,0.0001138194],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9467667,0.0009520715,0.003612964,0.0006872988,0.009932756,0.0003481056,0.005027798,0.00008026099,0.01510162,0.0002620353,0.001493436,0.01573499],"study_design_scores_gemma":[0.9731546,0.0006258443,0.002572642,0.001470517,0.009690162,0.000008172645,0.000900118,0.003674085,0.006280014,0.0002273437,0.00124025,0.0001562521],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9523346,0.02404289,0.00003326702,0.01638027,0.000835117,0.004920629,0.00007758992,0.0000336,0.001342016],"genre_scores_gemma":[0.9921746,0.001244405,0.00008102517,0.001318609,0.0001930333,0.0005036645,0.00009987847,0.00002235805,0.004362421],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03983998,"threshold_uncertainty_score":0.5422546,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02543317374760138,"score_gpt":0.4158875125835805,"score_spread":0.3904543388359791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}